Eric Fontas Selected Research

Anti-HIV Agents (AIDS Drugs)

10/2019	Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
11/2017	Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
1/2016	Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
1/2016	An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
3/2013	Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
10/2012	Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
10/2010	Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
2/2010	Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
2/2009	Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Fontas Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 10/2010
7	Myocardial Infarction 01/2018 - 04/2007
4	Infections 01/2020 - 01/2002
4	Vitiligo 01/2020 - 09/2004
3	Hypertension (High Blood Pressure) 01/2022 - 01/2005
3	Insulin Resistance 11/2021 - 06/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2021 - 02/2009
3	Osteoarthritis 01/2021 - 07/2007
3	Melanosis (Freckles) 07/2015 - 09/2011
3	Diabetes Mellitus 10/2012 - 02/2009
3	Lipodystrophy 10/2012 - 01/2005
2	Morbid Obesity 05/2022 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2022 - 12/2016
2	Pain (Aches) 01/2021 - 07/2007
2	Chronic Renal Insufficiency 10/2019 - 11/2017
2	Hemorrhage 01/2016 - 12/2012
2	Dyslipidemias (Dyslipidemia) 10/2012 - 04/2007
2	HIV Infections (HIV Infection) 10/2010 - 02/2010
1	Wounds and Injuries (Trauma) 05/2022
1	Fatty Liver 05/2022
1	Obesity 01/2022
1	Weight Gain 11/2021
1	Alopecia Areata 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Albuminuria 01/2020
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020
1	Proteinuria 01/2020
1	Hypertriglyceridemia 11/2018
1	Stroke (Strokes) 01/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 03/2016
1	Hepatic Encephalopathy 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Hepatorenal Syndrome 01/2016
1	End Stage Liver Disease 01/2016
1	Nail Diseases (Nail Disease) 07/2015
1	Atopic Dermatitis (Atopic Eczema) 04/2015
1	Neoplasms (Cancer) 10/2013
1	Lung Neoplasms (Lung Cancer) 10/2013
1	Hepatitis B 03/2013
1	Coinfection 03/2013

Drug/Important Bio-Agent (IBA)

9	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 02/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 01/2005
4	Reverse Transcriptase InhibitorsIBA 01/2022 - 01/2005
3	NucleosidesIBA 01/2022 - 01/2005
3	Interleukin-2 (IL2)IBA 01/2021 - 02/2009
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2005
2	Oxytocin (Pitocin)FDA LinkGeneric 05/2020 - 12/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2015 - 09/2004
2	CholesterolIBA 07/2011 - 01/2005
2	LipidsIBA 06/2008 - 04/2007
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2022
1	IntegrasesIBA 01/2022
1	Integrase InhibitorsIBA 01/2022
1	Raltegravir Potassium FDA Link 11/2021
1	dolutegravirIBA 11/2021
1	tenofovir alafenamideIBA 11/2021
1	4-hexyloxyaniline (HOA)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	EpitopesIBA 01/2020
1	AntibodiesIBA 01/2020
1	CreatinineIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	apremilastIBA 01/2020
1	3-ingenyl angelateIBA 01/2020
1	LeptinIBA 11/2018
1	BilirubinIBA 01/2018
1	ritonavir drug combination atazanavirIBA 01/2018
1	Atorvastatin (Lipitor)FDA Link 01/2018
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Ritonavir (Norvir)FDA Link 01/2018
1	abacavir (Ziagen)FDA Link 03/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Fetal Proteins (Fetoprotein)IBA 01/2016
1	Didanosine (Videx)FDA LinkGeneric 01/2016
1	Stavudine (Zerit)FDA LinkGeneric 01/2016
1	ametantrone (HAQ)IBA 07/2015
1	BromidesIBA 07/2015
1	CopperIBA 07/2015
1	Calcineurin InhibitorsIBA 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015
1	Ointments (Pastes)IBA 04/2015
1	Sunscreening Agents (Sunscreens)IBA 01/2015
1	N-acetoacetyl-N-deacetylcolchicineIBA 10/2013
1	FibrinIBA 12/2012

Therapy/Procedure

7	Therapeutics 11/2021 - 09/2004
4	Highly Active Antiretroviral Therapy (HAART) 10/2012 - 03/2006
2	Bariatric Surgery 05/2022 - 01/2022
2	Liver Transplantation 01/2022 - 01/2016
1	Operative Surgical Procedures 05/2022
1	Operative Time 05/2022
1	Art Therapy 01/2022
1	Precision Medicine 01/2020
1	Carotid Endarterectomy 01/2018
1	Lasers (Laser) 07/2015